Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections work best when placed in areas with adequate subcutaneous tissue, where the medication absorbs consistently into the bloodstream. PlexusDx patients using compounded semaglutide need clear guidance on site selection to maximize therapy effectiveness and minimize injection-related discomfort.

Approved Injection Sites for Semaglutide Administration

Semaglutide should be injected into the subcutaneous tissue—the fatty layer directly beneath your skin—in three primary body regions. The abdomen, thigh, and upper arm each contain sufficient tissue depth for proper medication delivery. Most patients find the abdomen most accessible for self-injection, as you can easily visualize the injection site and control needle angle.

The abdominal area offers a larger surface for rotation, reducing tissue irritation over time. Inject at least two finger-widths away from your belly button to avoid the sensitive periumbilical region. The outer thigh works well for patients with limited abdominal mobility or those preferring less visible injection marks. The upper arm (back of the triceps area) is suitable for injections, though self-administration can be awkward without assistance.

Rotating Injection Sites to Prevent Lipodystrophy

Injecting in the same spot repeatedly can cause lipodystrophy—a thickening or thinning of fat tissue that interferes with medication absorption and comfort. PlexusDx recommends establishing a rotation pattern across multiple injection sites to maintain consistent drug delivery. A practical approach involves dividing each approved body region into zones and moving systematically through them.

Within the abdomen, create an imaginary grid and select a new site at least one inch away from your previous injection. Many patients succeed with a monthly rotation cycle: Week 1 in the right abdomen, Week 2 in the left abdomen, Week 3 in the right thigh, and Week 4 in the left thigh. This pattern distributes injections evenly and prevents tissue damage. If you notice lumps, induration, or areas of unusual texture, skip that region until the tissue returns to normal.

Proper Injection Technique for Maximum Effectiveness

Effective semaglutide administration requires correct needle angle and injection depth. Hold the skin taut with one hand while using your dominant hand to insert the needle at a 90-degree angle (perpendicular to the skin). At this angle, the needle penetrates into the subcutaneous layer where semaglutide should be deposited. If you inject too superficially, the medication may leak out or absorb irregularly.

After inserting the needle, pause briefly before depressing the plunger to allow the needle to stabilize in the tissue. Inject slowly and steadily to reduce discomfort and ensure complete medication delivery. After injecting, remove the needle at the same 90-degree angle and apply gentle pressure with a clean cotton ball or gauze for 5–10 seconds. Avoid rubbing the injection site, as this can increase bleeding or bruising and theoretically affect absorption kinetics.

How PlexusDx Personalization Optimizes Your GLP-1 Therapy

Beyond proper injection technique, individual genetic differences affect how your body responds to semaglutide. PlexusDx offers the Precision Peptide Genetic Test, which identifies your unique genetic profile across 14 peptide pathways and 49 specific peptides. Key variants like GLP1R rs6923761 and GIPR rs1800437 influence your semaglutide sensitivity and optimal dosing trajectory, helping PlexusDx customize your therapy from day one.

When you understand your genetic predisposition to GLP-1 signaling efficiency, injection site management becomes part of a larger personalized strategy. The test results help PlexusDx predict your response trajectory so clinical adjustments can be made before you experience plateaus or suboptimal results. At $99 as an add-on after your first month of treatment, the Precision Peptide Genetic Test transforms semaglutide therapy from one-size-fits-all into precision medicine tailored to your biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into muscle instead of fat?

No—intramuscular injection of semaglutide is not recommended and may cause unexpected absorption patterns and tissue irritation. Always inject into the subcutaneous fat layer in your abdomen, thigh, or upper arm. If you are unsure whether you are hitting the correct tissue depth, ask your PlexusDx care team for an injection technique review.

How long after injection does semaglutide enter the bloodstream?

Subcutaneous semaglutide begins absorbing within minutes and reaches peak blood levels in 1–3 days, depending on injection site and individual tissue characteristics. Consistent rotation of injection sites helps maintain stable absorption rates and prevents the tissue changes that can delay or reduce drug availability.

What does PlexusDx semaglutide cost compared to brand-name Wegovy?

PlexusDx compounded semaglutide injections start at $149 per month, with pricing that stays flat regardless of your dose level—your dose may need to go up, but your price won't. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization, and injections are HSA/FSA eligible.

Is injection site bruising or swelling a reason to stop treatment?

Minor bruising and swelling are common and typically resolve within 24–48 hours. However, persistent swelling, warmth, or signs of infection require immediate attention. If you develop lipodystrophy (thickened or hardened tissue), avoid that site for several weeks and consult your PlexusDx care team, as altered tissue may reduce medication absorption.

How does the Precision Peptide Genetic Test help with semaglutide injections?

The test identifies your genetic variants in GLP1R and GIPR pathways, which predict how efficiently your body responds to semaglutide signaling. This information helps PlexusDx design a personalized dosing schedule and monitor your progress, so injection technique combined with genetic insight optimizes your weight loss outcomes.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves